Histoplasmosis peritonitis in an immunocompetent patient: case report.

Thomas Jaugey, Michael Schneider, Cristina Bellini, Stephane Yerly, Charalampos Sotiriadis, Edgardo Pezzetta
Author Information
  1. Thomas Jaugey: Department of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.
  2. Michael Schneider: Department of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland. michael.schneider@chuv.ch.
  3. Cristina Bellini: Service of Infectious Diseases, Central Institute, Valais Hospitals, Sion, Switzerland.
  4. Stephane Yerly: Histocytopathology, Service of Histocytopathology, Central Institute, Valais Romand Hospitals, Sion, Valais, Switzerland.
  5. Charalampos Sotiriadis: Department of Medical Imaging, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.
  6. Edgardo Pezzetta: Department of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.

Abstract

Histoplasmosis is a fungal infection most frequently seen in immunocompromised patients. It is endemic in Central and South America and in Africa. The infection is usually asymptomatic in a healthy individual. Extrapulmonary dissemination can be seen in immunocompromised hosts. Gastrointestinal manifestations frequently involve the terminal ileum and cecum, mimicking Crohn's disease or malignancy. We describe the case of a 36-year-old healthy man from Cameroon, living in Switzerland for 13 years and without any medical nor surgical history, who presented peritonitis not responding to antibiotics. CT-scan showed bowel obstruction and signs of peritonitis. We opted for an explorative laparoscopy, which was converted to laparotomy with extensive adhesiolysis. Diagnostic of histoplasmosis was confirmed by histology and PCR analysis on biopsy. To our knowledge, this is the first described case of peritonitis as main outcome of a disseminated histoplasmosis involving the peritoneum in an immunocompetent patient.

Keywords

References

  1. BMC Infect Dis. 2019 Nov 21;19(1):992 [PMID: 31752711]
  2. World J Gastrointest Endosc. 2021 Jan 16;13(1):24-32 [PMID: 33520104]
  3. Life (Basel). 2023 Mar 03;13(3): [PMID: 36983844]
  4. BMC Infect Dis. 2018 Dec 18;18(1):673 [PMID: 30563472]
  5. Antimicrob Agents Chemother. 2001 Aug;45(8):2354-7 [PMID: 11451696]
  6. Infect Dis Clin North Am. 2021 Jun;35(2):471-491 [PMID: 34016287]
  7. Clin Infect Dis. 2000 Apr;30(4):688-95 [PMID: 10770731]
  8. Clin J Gastroenterol. 2013 Aug;6(4):315-8 [PMID: 26181736]
  9. Am J Trop Med Hyg. 2014 Jun;90(6):982-983 [PMID: 24778192]
  10. Rev Med Suisse. 2009 Nov 25;5(227):2418-23 [PMID: 20052843]
  11. Cureus. 2020 Dec 25;12(12):e12277 [PMID: 33510984]
  12. BMJ Case Rep. 2013 Jun 27;2013: [PMID: 23814195]

MeSH Term

Male
Humans
Adult
Histoplasmosis
Crohn Disease
Intestinal Obstruction
Peritonitis
Cameroon

Word Cloud

Created with Highcharts 10.0.0peritonitiscasehistoplasmosisHistoplasmosisinfectionfrequentlyseenimmunocompromisedhealthyimmunocompetentfungalpatientsendemicCentralSouthAmericaAfricausuallyasymptomaticindividualExtrapulmonarydisseminationcanhostsGastrointestinalmanifestationsinvolveterminalileumcecummimickingCrohn'sdiseasemalignancydescribe36-year-oldmanCameroonlivingSwitzerland13yearswithoutmedicalsurgicalhistorypresentedrespondingantibioticsCT-scanshowedbowelobstructionsignsoptedexplorativelaparoscopyconvertedlaparotomyextensiveadhesiolysisDiagnosticconfirmedhistologyPCRanalysisbiopsyknowledgefirstdescribedmainoutcomedisseminatedinvolvingperitoneumpatientpatient:reportAbdominalpainDisseminatedImmunocompetent

Similar Articles

Cited By